跳至主要内容
临床试验/NCT06742060
NCT06742060招募中不适用

A Study on the Trend of Serum Copeptin Levels and Its Clinical Value for Postoperative Central Diabetes Insipidus in Pediatric Patients After Neurosurgical Intervention in Intensive Care Unit

Children's Hospital of Fudan University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年11月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
C0-C6:The serum concentration of copeptin after NSI at T0 -T6

研究概览

简要总结

Central diabetes insipidus (CDI),a disease caused by the decrease of AVP (a hormone involved in the control of water-electrolyte balance ) secretion and characerized by polyuria, is a common complication after neurosurgerical intervention and there is a lack of diagnostic criteria.Since the surgry casuses damage to patients' AVP-secreting neuronal cells, transient CDI (t-CDI) usually occurs 24-48h postoperatively and gradually resolves in about 10 days.However,permanent CDI (p-CDI) occurs in a small percentage of patients.Copeptin is a fragment of AVP, which has been shown to response the secretion of AVP.Multiple international studies have identified clinical applications for the use of copeptin to differentially diagnose adults with CDI , to assess electrolyte disturbances associated with AVP regulation, and to predict postoperative CDI after pituitary surgery.This study aims to investigate the trend of serum copeptin levels and its clinical value for postoperative CDI in pediatric patients after neurosurgerical intervention in ICU.

详细描述

In children and adolescents, the concentration distribution of copeptin has been gradually explored in recent years,but International studies have not yet shown the trend of copeptin levels in pediatric patients after neurosurgical intervention and its value in predicting CDI.

The primary objective of this study is to investigate the trend of serum copetin levels in ICU children after neurosurgerical intervention and compare differences of copeptide levels in children with CDI (t-CDI, p-CDI) and non-CDI. The secondary objective is to evaluate the optimal detection time and CUT OFF of copeptin in predicting the postoperative secondary CDI .

Blood sampling time points of serum copeptin levels are listed as follow:

presurgery(T0), 1h (T1), 1 day (T2), 2 days (T3), 3 days (T4), 4 days (T5), 5 day (T6) after surgury.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
29 Days 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female,age ≥29 days and <18 years
  • After neurosurgical intervention
  • The patient agrees to comply with the requirements of the program, including follow-up visits and other related matters

排除标准

  • Structural diseases of the genitourinary system (with the possibility of nephrogenic diabetes insipidus)
  • Preoperative symptoms of diabetes insipidus
  • Diabetes mellitus (HbA1c >8.5%)
  • Drugs causing excessive drinking and urination (e.g., sodium-glucose cotransporter-2 inhibitors and diuretics)
  • Lack of follow-up data after 3 months

结局指标

主要结局

C0-C6:The serum concentration of copeptin after NSI at T0 -T6

时间窗: Day0-6

The serum concentration of copeptin after NSI at T0 -T6 to evaluate the trend of copetin level after NSI and its difference in children with CDI(t-CDI and p-CDI) and non-CDI

次要结局

  • ROC curve(Day0-6)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验